An effective treatment with an established safety profile for an infantile hemangioma (IH)
When it comes to IH, early action matters
The First and Only FDA-Approved Treatment for a Proliferating Infantile Hemangioma Requiring Systemic Therapy
Learn More About HEMANGEOL- FDA-Approved
- First and only oral treatment for proliferating infantile hemangioma
- Formulated for Infants
- Alcohol-free
- Sugar-free
- Paraben-free oral solution
- Supported by Eton Cares®
- $0 monthly copay for eligible patients
- Dedicated support
*Restrictions, limitations, and/or eligibility requirements may apply.
Clinically proven safety and effectiveness profile.
6 out of 10 babies on HEMANGEOL had their infantile hemangioma lesion “completely or nearly completely resolved” by 6 months of therapy versus only 4% of babies who received no treatment (n=101).1
*Of patients on HEMANGEOL 3.4 mg/kg/day for 6 months who were considered successes, 10% required retreatment for recurrence of hemangiomas.
Nearly 9 out of 10 of the babies treated with HEMANGEOL showed improvement by 5 weeks, compared with 5% of babies who received no treatment (n=55)2.
*Based on independent-investigator assessment of telangiectasis, color, textural change, and distortion of anatomical landmarks or skin contours compared to baseline.
Less than 2 of 100 babies given HEMANGEOL had to stop treatment due to adverse experiences, reflecting a well-established safety profile in infants.1
The most common side effects (>10%) were sleep problems, worsening respiratory tract infections, diarrhea, and vomiting — most were mild and manageable with your doctor’s guidance.1
HEMANGEOL can cause serious side effects, including low blood sugar (hypoglycemia), especially if your child is not taking feedings, or is vomiting.
Please read additional Important Safety Information for HEMANGEOL.
Your rare disease journey is personal. So is our support.
When your doctor prescribes HEMANGEOL, you’re automatically enrolled in the Eton Cares Patient Support—designed to support you and your family every step of the way with welcome calls, insurance verification, financial assistance, and ongoing pharmacy support.
*Restrictions, limitations, and/or eligibility requirements may apply.
Learn About Eton Cares
How to get HEMANGEOL.
Once your doctor writes a prescription, the Eton Cares Patient Support and our specialty pharmacy partner take care of the rest — from insurance verification to delivery.
How to Get HEMANGEOL
Everything you need, in one place.
Visit our Support & Resources page for downloadable patient brochures and instructions, frequently asked questions, partner advocacy organizations, the HEMANGIOM’ App, and a list of questions to bring to your next doctor’s visit.
Visit Support & ResourcesReferences
- HEMANGEOL Prescribing Information. Eton Pharmaceuticals.
- Léauté-Labrèze C, et al. A randomized, controlled trial of oral propranolol in infantile hemangioma. N Engl J Med. 2015;372:735-746.